Embodies the targeted and rational treatment of diseases according to specific molecular alterations underlying an individual patient’s disease. It is now well-established that many of the NCDs have an underlying genetic basis caused by inherited and acquired genomic aberrations.
The Promise of
Precision Molecular Diagnostics
The advent of advanced genetics and proteomics research has given scientists and clinicians new insight into fundamental disease mechanisms and normal physiology.
This insight has now made possible the development of therapeutics and interventions that can be individualized to the patient and can in some instances be administered before the disease even presents – or at the very least, before it leads to any significant and debilitating symptoms.
The Promise of
The promise of Personalized medicine postulates that diseases can be treated more effectively, and even possibly cured, through understanding and targeting key driver genomic aberrations.
Advanced Disease Management
Complex diseases cannot usually be attributed to only one genetic abnormality; the expression and severity of a disease often results from the effects of multiple genes.
The identification of “disease signatures” using artificial intelligence and machine learning will become increasingly important to fully understand the disease. These discoveries will be crucial for the identification of molecular targets for both diagnosis and therapy.
Patient samples are collected using the least invasive approach – normally only a blood or saliva sample is required, also known as a “Liquid Biopsy”. Other types of samples include Skin Punch Biopsy and from time to time other Tissue Biopsy, only if necessary.